When news broke on August 18 that the Food and Drug Administration approved Addyi, the pill that is being incorrectly referred to as the “female Viagra,” it might have seemed like an obvious feminist win. Viagra has been around since 1998, but there hasn’t been anything remotely comparable on the market for women. Addyi is supposed to alleviate female hypoactive sexual desire disorder (or lack of sexual desire). But as we’ve reported, women on Addyi experienced an increase of only one sexual event per month during clinical trials.
Here’s What Sexperts Think About Female Viagra and Why You Shouldn’t Call It That
